Legal & General Group
LBRX

Legal & General Group’s LB Pharmaceuticals LBRX Stock Holding History

Legal & General Group’s Portfolio LBRX Stock Details LBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$319K Buy
9,838
+8,115
+471% +$238K ﹤0.01% 2493
2026
Q1 		$42.5K Sell
1,723
-155
-8% -$3.58K ﹤0.01% 2715
2025
Q4 		$41.8K Buy
+1,878
New +$32.8K ﹤0.01% 2773

Other funds holding LBRX

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Legal & General Group's LBRX Position: Q2 2026 in Review

Legal & General Group increased its LB Pharmaceuticals (LBRX) stake by 471% in Q2 2026, buying an estimated $238K and bringing the position to 9,838 shares worth $319K. The position accounts for ﹤0.01% of the portfolio, ranked #2493.

Legal & General Group first reported a position in LBRX in Q4 2025 and has held it in 3 quarters since. 114 funds tracked by Wall St. Rank hold LBRX as of Q2 2026.

  • Legal & General Group held 9,838 shares of LB Pharmaceuticals worth $319K as of Q2 2026.
  • Legal & General Group bought 8,115 LB Pharmaceuticals shares in Q2 2026, an estimated $238K.
  • LB Pharmaceuticals made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2493 holding.
  • Legal & General Group first reported a position in LB Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 114 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.